ask="20.75"
ask_size="300"
average_daily_volume="348018"
bid="18.00"
bid_size="100"
book_value="3.21"
change="+1.01"
change_from_200_day_moving_average="6.78"
change_from_50_day_moving_average="1.98"
change_from_52_week_high="-2.91"
change_From_52_week_low="14.99"
change_in_percent="+5.27%"
close="20.16"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.47"
ex_dividend_date="N/A"
float_shares="7129000"
high="20.44"
high_52_weeks="23.07"
last_trade_date="2/10/2017"
last_trade_price="20.16"
last_trade_size="7052"
last_trade_time="4:00pm"
low="19.20"
low_52_weeks="5.17"
market_capitalization="200.65M"
moving_average_200_day="13.38"
moving_average_50_day="18.18"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="19.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+50.64%"
percent_change_from_50_day_moving_average="+10.91%"
percent_change_from_52_week_high="-12.61%"
percent_change_from_52_week_low="+289.94%"
previous_close="19.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.97"
price_per_sales="3372.02"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="7.19"
stock_exchange="NGM"
symbol="ZYNE"
volume="453762"
weeks_range_52="5.17 - 23.07"
